Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gen Sheng Wu

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Cancer Biology & Therapy|July 25, 2012
Cullin-3 protein expression levels correlate with breast cancer progressionKelly K Haagenson, Larry Tait, Juan Wang, et al.
Current Issues in Molecular Biology|October 28, 2025
Regulation of PD-L1 Protein Expression by the E3 Ubiquitin Ligase GP78Madhumita Chatterjee, Julio M Pimentel, Jun-Ying Zhou, et al.
Oncotargets and Therapy|February 9, 2016
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosisHanxiao Xu, Yijun Tian, Xun Yuan, et al.
International Journal of Oncology|August 9, 2016
CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancerHanxiao Xu, Kongju Wu, Yijun Tian, et al.
Frontiers in Oncology|July 18, 2022
Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor ResistanceMohammed Hafiz Uddin, Jun-Ying Zhou, Julio Pimentel, et al.
Molecular Cancer|May 1, 2015
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Molecular Cancer|October 18, 2024
Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Cancer Biology & Therapy|December 25, 2008
TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell deathKageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, et al.
Medicine|July 12, 2016
Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysisHan-Xiao Xu, Kong-Ju Wu, Yi-Jun Tian, et al.
Biochemical Pharmacology|August 10, 2014
MCL-1 dependency of cisplatin-resistant cancer cellsJudith Michels, Florine Obrist, Ilio Vitale, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Cancer Biology & Therapy|July 25, 2012
Cullin-3 protein expression levels correlate with breast cancer progressionKelly K Haagenson, Larry Tait, Juan Wang, et al.
Current Issues in Molecular Biology|October 28, 2025
Regulation of PD-L1 Protein Expression by the E3 Ubiquitin Ligase GP78Madhumita Chatterjee, Julio M Pimentel, Jun-Ying Zhou, et al.
Oncotargets and Therapy|February 9, 2016
Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosisHanxiao Xu, Yijun Tian, Xun Yuan, et al.
International Journal of Oncology|August 9, 2016
CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancerHanxiao Xu, Kongju Wu, Yijun Tian, et al.
Frontiers in Oncology|July 18, 2022
Proteomic Analysis Identifies p62/SQSTM1 as a Critical Player in PARP Inhibitor ResistanceMohammed Hafiz Uddin, Jun-Ying Zhou, Julio Pimentel, et al.
Molecular Cancer|May 1, 2015
Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Molecular Cancer|October 18, 2024
Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathwayJoshua E Allen, Gabriel Krigsfeld, Luv Patel, et al.
Cancer Biology & Therapy|December 25, 2008
TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell deathKageaki Kuribayashi, Gabriel Krigsfeld, Wenge Wang, et al.
Medicine|July 12, 2016
Expression profile of SIX family members correlates with clinic-pathological features and prognosis of breast cancer: A systematic review and meta-analysisHan-Xiao Xu, Kong-Ju Wu, Yi-Jun Tian, et al.
Biochemical Pharmacology|August 10, 2014
MCL-1 dependency of cisplatin-resistant cancer cellsJudith Michels, Florine Obrist, Ilio Vitale, et al.
Pageof 7